03 9457 4445

Providing a specialist Endocrinology service to every corner of Australia.

Denosumab Treatment For Osteoporosis Remains Beneficial Over 10 Years

New research presented at the American Society for Bone and Mineral Research 2015 Annual Meeting shows that aging postmenopausal women who received denosumab (Prolia) over 10 years continued to gain bone mineral density and had low incidences of fracture. Particularly “striking” was the lumbar spine bone density which increased 21.7% over the 7 year study.


Back to Blog